Hossein Borghaei, DO
Fox Chase Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hossein Borghaei, DO as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:21 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07854769 · Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung CancerFox Chase Cancer Center · not yet recruiting · Non Small Cell Lung Cancer · principal investigator
- Ph2NCT05400577 · Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLCFox Chase Cancer Center · withdrawn · Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT03527108 · Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLCFox Chase Cancer Center · active not recruiting · Non Small Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT01471964 · Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung CancerFox Chase Cancer Center · terminated · Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer Recurrent · principal investigator
- Ph2NCT00553800 · Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerFox Chase Cancer Center · completed · Carcinoma, Non-Small-Cell Lung · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.